Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins
- 1 February 1999
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (2) , 569
- https://doi.org/10.1200/jco.1999.17.2.569
Abstract
PURPOSE: The incidence of secondary leukemia after epipodophyllotoxin treatment and the relationship between epipodophyllotoxin cumulative dose and risk are not well characterized. The Cancer Thera...Keywords
This publication has 47 references indexed in Scilit:
- Risk of Secondary Leukemia Following High Cumulative Doses of Etoposide During Chemotherapy for Testicular CancerJNCI Journal of the National Cancer Institute, 1995
- Secondary tumours following etoposide containing therapy for germ cell cancerAnnals of Oncology, 1995
- Therapy‐related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risksMedical and Pediatric Oncology, 1994
- Acute Nonlymphocytic Leukemia in Germ Cell Tumor Patients Treated With Etoposide-Containing ChemotherapyJNCI Journal of the National Cancer Institute, 1993
- Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1991
- Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.Journal of Clinical Oncology, 1991
- Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell TumorsNew England Journal of Medicine, 1990
- Cytogenetic and Immunohistochemical Evidence for the Germ Cell Origin of a Subset of Acute Leukemias Associated With Mediastinal Germ Cell TumorsJNCI Journal of the National Cancer Institute, 1990
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987